DJIA 17,142.20 111.06 0.65%
NASDAQ 4,555.52 36.62 0.81%
S&P 500 2,000.02 15.89 0.80%
market minute promo

270.98 4.89 (1.84%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IBB $270.98 1.84%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $264.73
Previous Close $266.09
Daily Range $264.05 - $271.45
52-Week Range $191.29 - $278.78
Market Cap $5.4B
P/E Ratio -1,156.91
Dividend (Yield) $1.57 (0.1%)
Ex-Dividend Date
Dividend Pay Date
06/25/14
07/01/14
Volume 1,081,896
Average Daily Volume 918,331
Current FY EPS $0.00

Sector

Financials

Industry

Financial Services

iShares NASDAQ Biotechnology Index (ETF) (IBB) Description

The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index). Website: http://www.ishares.com/

News & Commentary

3 Reasons Actavis plc Stock Could Fall

Shares of specialty drugmaker Actavis have been ripping higher over the past two years. Here are three reasons why this trend could be coming to an end.

Bulls Go Down Swinging, Refusing To Give Up Much Ground

Biotech ETFs Slip on Gilead Weakness; Buying Opportunity Now? - ETF News And Commentary

Buy the Dips in This Resilient Market

Arrowhead Research Corp Heads Higher After Breakout

Biotechnology ETFs Show Robust Health In August

IBB, CELG, BIIB, ALXN: ETF Outflow Alert

Biotechnology, Oil And Brazil ETFs To Watch This Week

Bulls Power Through Geopolitical Tensions for a Strong Finish

Today's financial recap and tomorrow's financial outlook.

Isis Pharmaceuticals Finally Breaks Out

See More IBB News...

IBB's Top Competitors

IBB $270.98 (1.84%)
Current stock: IBB
VTA $12.44 (0.44%)
Current stock: VTA
NCV $9.88 (0.82%)
Current stock: NCV
ZTR $14.07 (0.43%)
Current stock: ZTR